LONDON (AP) — Anglo-Swedish drug-maker AstraZeneca PLC reported a 7 percent fall in net profit for the first quarter of 2015, as cheaper copies of one of its best-sellers ate into sales. [...] AstraZeneca reported 45 percent growth in sales of heart drug Brilinta, and 18 percent growth in emerging markets.